System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Practice Guideline Ppublish 20 citations

PubMed: 39216500 DOI: 10.1016/S1470-2045(24)00262-6

Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.

Lancet Oncol 25(11):e602-e610

Authors: Philippe Morice, Giovanni Scambia, Nadeem R Abu-Rustum, Maribel Acien, Alessandro Arena, Sara Brucker, Ying Cheong, Pierre Collinet, Francesco Fanfani, Francesca Filippi, Ane Gerda Zahl Eriksson, Sebastien Gouy, Philipp Harter, Xavier Matias-Guiu, George Pados, Maja Pakiz, Denis Querleu, Alexandros Rodolakis, Christine Rousset-Jablonski, Artem Stepanyan, Antonia Carla Testa, Kirsten Tryde Macklon, Dimitrios Tsolakidis, Michel De Vos, François Planchamp, Michaël Grynberg

Affiliations

  • Department of Gynecological Surgery, Gustave Roussy Cancer Campus, Villejuif, France; Université Paris Saclay, Paris, France.
  • Department of Women, Children, and Public Health Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
  • Gynecologic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Institute of Women's Health, University College London, London, UK; Grant Next Generation Department of Gynecology, Miguel Hernandez University, Alicante, Spain.
  • Division of Gynaecology and Human Reproduction Physiopathology, IRCCS, Azienda Ospedaliero-Univeristaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
  • Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Unité de Chirurgie Gynécologique, Hôpital Privé le Bois, Groupe Ramsay Lille Metropole, Lille, France.
  • Infertility Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Department of Gynecological Surgery, Gustave Roussy Cancer Campus, Villejuif, France; Université Paris Saclay, Paris, France.
  • Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
  • Department of Pathology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Department of Obstetrics and Gynaecology, Papageorgiou General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department for Gynaecologic and Breast Oncology, University Medical Center Maribor, Maribor, Slovenia.
  • Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
  • Unit of Gynaecologic Oncology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Surgery, Centre Léon Bérard, Lyon, France; Obstetrics and Gynecology, Hôpital Femme Mère Enfant, Bron, France.
  • Gynecologic Oncology Service, Nairi Medical Center, Yerevan, Armenia.
  • Fertility Clinic, Department of Gynecology, Fertility and Obstetrics Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Centre for Reproductive Medicine, University Hospital Brussels, Brussels, Belgium; Follicle Biology Laboratory, Vrije Universiteit Brussel, Brussels, Belgium.
  • Institut Bergonié, Bordeaux, France.
  • Université Paris Saclay, Paris, France; Department of Reproductive Medicine and Fertility Preservation, Hopital Antoine Béclère, Clamart, France; Department of Reproductive Medicine and Fertility Preservation, Hopital Jean Verdier, Bondy, France.

Abstract

The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing strategies and follow-up of patients with cervical cancers, ovarian cancers, and borderline ovarian tumours. The developmental process of these guidelines is based on a systematic literature review and critical appraisal involving an international multidisciplinary development group consisting of 25 experts from relevant disciplines (ie, gynaecological oncology, oncofertility, reproductive surgery, endoscopy, imaging, conservative surgery, medical oncology, and histopathology). Before publication, the guidelines were reviewed by 121 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover oncological aspects of fertility-sparing strategies during the initial management, optimisation of fertility results and infertility management, and the patient's desire for future pregnancy and beyond.

MeSH

Fertility, Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Therapeutics

Cited by